BTIG upgraded Liquidia to ‘Buy’ from ‘Neutral’ with a $70 price target, implying about 93% upside from current levels.
LQDA Stock Rockets 40% Today – BTIG Calls United Therapeutics Settlement ‘Better Than Best-Case Scenario’
view original post
BTIG upgraded Liquidia to ‘Buy’ from ‘Neutral’ with a $70 price target, implying about 93% upside from current levels.